These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 2884455

  • 1. Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants.
    Hanlon P, Hanlon L, Marsh V, Byass P, Shenton F, Hassan-King M, Jobe O, Sillah H, Hayes R, M'Boge BH.
    Lancet; 1987 Jun 13; 1(8546):1342-5. PubMed ID: 2884455
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunogenicity and reactogenicity of rhesus rotavirus vaccine given in combination with oral or inactivated poliovirus vaccines and diphtheria-tetanus-pertussis vaccine.
    Jalil F, Zaman S, Carlsson B, Glass RI, Kapikian AZ, Mellander L, Hanson LA.
    Trans R Soc Trop Med Hyg; 1991 Jun 13; 85(2):292-6. PubMed ID: 1653474
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Safety and immunogenicity of bovine rotavirus vaccine RIT 4237 in 3-month-old infants.
    Maldonado Y, Hestvik L, Wilson M, Townsend T, O'Hare J, Wee S, Yolken R.
    J Pediatr; 1986 Dec 13; 109(6):931-5. PubMed ID: 3537248
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group.
    Bernstein DI, Glass RI, Rodgers G, Davidson BL, Sack DA.
    JAMA; 1995 Apr 19; 273(15):1191-6. PubMed ID: 7707626
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
    Vesikari T, Joensuu J, Baer M, Käyhty H, Olander RM, Sormunen H, Miettinen A, Ward RL, Guillot T.
    Acta Paediatr; 1999 May 19; 88(5):513-20. PubMed ID: 10426173
    [Abstract] [Full Text] [Related]

  • 19. Concurrent oral poliovirus and rhesus-human reassortant rotavirus vaccination: effects on immune responses to both vaccines and on efficacy of rotavirus vaccines. The US Rotavirus Vaccine Efficacy Group.
    Rennels MB, Ward RL, Mack ME, Zito ET.
    J Infect Dis; 1996 Feb 19; 173(2):306-13. PubMed ID: 8568290
    [Abstract] [Full Text] [Related]

  • 20. The "Performance of Rotavirus and Oral Polio Vaccines in Developing Countries" (PROVIDE) study: description of methods of an interventional study designed to explore complex biologic problems.
    Kirkpatrick BD, Colgate ER, Mychaleckyj JC, Haque R, Dickson DM, Carmolli MP, Nayak U, Taniuchi M, Naylor C, Qadri F, Ma JZ, Alam M, Walsh MC, Diehl SA, PROVIDE Study Teams, Petri WA.
    Am J Trop Med Hyg; 2015 Apr 19; 92(4):744-51. PubMed ID: 25711607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.